Supernus Pharmaceuticals, Inc. (SUPN)

NASDAQ: SUPN · IEX Real-Time Price · USD

30.25

+1.15 (3.95%)

At close: Jul 19, 2024, 12:00 AM

30.29

+0.04 (0.13%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Supernus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2009
Net Income	-15.51	1.32	60.71	53.42	126.95	113.06	Upgrade
Depreciation & Amortization	85.01	84.86	85.54	32.6	18.14	6.66	Upgrade
Share-Based Compensation	26.35	26.76	17.57	17.91	16.56	14.85	Upgrade
Other Operating Activities	4.51	-1.85	-47	23.2	-23.25	8.57	Upgrade
Operating Cash Flow	100.36	111.09	116.83	127.13	138.4	143.13	Upgrade
Operating Cash Flow Growth	-37.92%	-4.91%	-8.10%	-8.14%	-3.30%	10.96%	Upgrade
Capital Expenditures	-0.52	-0.55	-0.41	-2.05	-3.69	-1.39	Upgrade
Acquisitions	0	0	0	-298.8	-313.54	0	Upgrade
Change in Investments	-22.15	269.28	-216.25	218.94	282.53	-156.54	Upgrade
Investing Cash Flow	-22.68	268.73	-216.66	-81.91	-34.7	-157.92	Upgrade
Share Issuance / Repurchase	7.71	6.61	12.42	7.1	4.36	3.93	Upgrade
Debt Issued / Paid	-480.86	-402.5	0	-137.52	-0.8	0	Upgrade
Other Financing Activities	-3.33	-1.99	-22.9	-	-	-	Upgrade
Financing Cash Flow	-476.48	-397.88	-10.48	-130.42	3.56	3.93	Upgrade
Net Cash Flow	-398.8	-18.07	-110.31	-85.21	107.26	-10.87	Upgrade
Free Cash Flow	99.84	110.53	116.41	125.08	134.71	141.74	Upgrade
Free Cash Flow Growth	-38.30%	-5.05%	-6.93%	-7.15%	-4.96%	10.61%	Upgrade
Free Cash Flow Margin	16.71%	18.19%	17.45%	21.57%	25.89%	36.09%	Upgrade
Free Cash Flow Per Share	1.82	2.03	2.17	2.36	2.56	2.70	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).